Biopharma | May 18, 2026
Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Paves way for CNS cancer test rollout
The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Subscribe To Our Newsletter & Stay Updated
